Platelet-activating factor is a phospholipid-derived signaling hormone involved in platelet aggregation, inflammatory communication, vascular permeability regulation, immune-cell activation, and bronchial responsiveness. PAF functions as a potent mediator linking coagulation pathways with inflammatory and immune signaling systems. Through these actions, it contributes to vascular adaptation, leukocyte recruitment, endothelial signaling, and acute inflammatory responses.
The hormone influences platelet activation, vasodilation or vasoconstriction depending on tissue context, smooth muscle responsiveness, bronchial signaling, and cytokine production. PAF also participates in communication between endothelial cells, neutrophils, macrophages, eosinophils, and platelets during immune activation and tissue stress.
PAF is synthesized from membrane phospholipid precursors through remodeling pathways activated during cellular stimulation. Production occurs in platelets, neutrophils, macrophages, mast cells, endothelial cells, eosinophils, and additional inflammatory tissues. Phospholipase-mediated reactions generate lysophospholipid intermediates that are acetylated to produce active platelet-activating factor.
Because PAF is synthesized rapidly in response to stimulation rather than stored in large quantities, production closely reflects inflammatory signaling intensity and cellular activation status. Local synthesis allows highly targeted tissue-specific responses during immune and vascular activation.
PAF production is regulated by inflammatory cytokines, oxidative stress, immune receptor activation, phospholipase signaling pathways, calcium mobilization, and endothelial stimulation. Allergic signaling, tissue injury, microbial recognition pathways, and coagulation-related activation can strongly increase synthesis.
PAF acts through platelet-activating factor receptors distributed on platelets, leukocytes, endothelial cells, respiratory tissues, and vascular smooth muscle. Receptor activation stimulates calcium signaling, phospholipase pathways, cytokine release, platelet aggregation, and vascular permeability responses. Enzymatic degradation by platelet-activating factor acetylhydrolase helps regulate signaling duration and maintain tissue balance. Through these integrated phospholipid-signaling systems, PAF coordinates inflammatory adaptation, coagulation communication, vascular responsiveness, and immune-cell activation.
PAF is a membrane-derived lipid mediator that modulates platelet activation and immune cell interactions.
